VEA
PRVB
Virtus ETF Advisers’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-31,657
| Closed | -$763K | – | 493 |
|
|
2023
Q1 | $763K | Buy |
31,657
+562
| +2% | +$13.5K | 0.42% | 117 |
|
|
2022
Q4 | $329K | Buy |
+31,095
| New | +$329K | 0.17% | 234 |
|
|
2022
Q2 | – | Sell |
-26,467
| Closed | -$194K | – | 493 |
|
|
2022
Q1 | $194K | Sell |
26,467
-1,563
| -6% | -$11.5K | 0.09% | 200 |
|
|
2021
Q4 | $158K | Buy |
28,030
+4,363
| +18% | +$24.6K | 0.06% | 333 |
|
|
2021
Q3 | $151K | Sell |
23,667
-1,242
| -5% | -$7.92K | 0.07% | 338 |
|
|
2021
Q2 | $210K | Buy |
24,909
+8,751
| +54% | +$73.8K | 0.09% | 313 |
|
|
2021
Q1 | $170K | Buy |
16,158
+280
| +2% | +$2.95K | 0.07% | 342 |
|
|
2020
Q4 | $269K | Sell |
15,878
-5,607
| -26% | -$95K | 0.11% | 282 |
|
|
2020
Q3 | $276K | Sell |
21,485
-2,916
| -12% | -$37.5K | 0.14% | 243 |
|
|
2020
Q2 | $344K | Sell |
24,401
-6,256
| -20% | -$88.2K | 0.16% | 270 |
|
|
2020
Q1 | $282K | Sell |
30,657
-4,461
| -13% | -$41K | 0.12% | 235 |
|
|
2019
Q4 | $523K | Buy |
+35,118
| New | +$523K | 0.09% | 200 |
|